Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in Locally Advanced Cervical Cancer.

NCT04275713 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04275713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04275713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in Locally Advanced Cervical Cancer.
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Completed
Start date
May 22, 2020
Completion date
November 8, 2024
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer